What is it about?
Considerable CVD risk reduction with decrease in HbA1c, blood pressure and blood lipids in type 2 diabetes during 7 years of follow-up
Featured Image
Why is it important?
Decrease in CVD risk has previously been difficult to demonstrate for HbA1c in randomised trials, now showed here, and also showed of considerable degree with combined decreases for HbA1c, blood pressure and blood lipids.
Perspectives
Large observational studies of patients in daily clinical practice demonstrating CVD risk decrease with lowering of cardiovascular risk factors are of importance as complement to randomised trials.
Ass Prof Jan Cederholm
Dpt of Public Health and Caring Sciences/Family Medicine
Read the Original
This page is a summary of: Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register, Diabetes and Vascular Disease Research, April 2016, SAGE Publications,
DOI: 10.1177/1479164116637311.
You can read the full text:
Contributors
The following have contributed to this page
